Abstract
The titers of components of the plasma kallikrein-kinin system have been measured conventionally by their biological functions. The functional assays are, however, antagonized by the presence of inhibitors and/or the absence of potentiators in test samples. Immunologic assays obviate these difficulties. We have developed specific, sensitive and reproducible radioimmunoassays (RIA) for HF and prekallikrein, and have applied these assays to some clinical conditions. Normal pooled human plasma contained approximately 40 μg of HF and 50 μg of prekallikrein per ml. RIA were able to measure concentrations of HF and prekallikrein as low as 0.1% and 0.3% that of normal pooled plasma respectively. A good correlation existed between titers measured by clotting and radioimmunoassays among 40 normal subjects (correlation co-efficient = 0.82 for HF and 0.71 for prekallikrein). There was no significant difference between the levels of HF and prekallikrein in plasma and those in serum. Both HF and prekallikrein were significantly reduced in plasmas of patients with advanced liver cirrhosis or disseminated intravascular coagulation (DIC) and in cord serums, but they were normal in plasmas obtained after strenuous physical exercise and in plasmas of patients under treatment with warfarin.
Chapter PDF
Similar content being viewed by others
Keywords
- Disseminate Intravascular Coagulation
- Disseminate Intravascular Coagulation
- Strenuous Physical Exercise
- Cord Serum
- High Molecular Weight Kininogen
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Amundsen, E., L. Svendsen, A.M. Vennerd, and K. Laake. 1977. Determination of plasma kallikrein with a new chromogenic tripeptide derivative. In: Chemistry and Biology of KallikreinKinin System in Health and Disease. Pisano, J.J. and Austen, K.F. (eds.) (DREW Pub. No. 76–791, Washington, D.C. p. 215 ).
Bagdassarian, A., B. Lahiri, R.C. Talamo, P. Wong and R.W. Colman. 1974. Immunochemical Studies of Plasma Kallikren. J. Clin. Invest. 54: 1444.
Colman, R.W., J.W. Mason and S. Sherry. 1969. The kallikreinogenkallikrein enzyme system of human plasma. Assay of components and observations in disease states. Ann. Intern. Med. 71: 763.
Donaldson, V.H., J. Kleniewski, H. Saito and J.K. Sayed. 1977. Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma. J. Clin. Invest. 60: 571.
Hathaway, W.E., L.P. Belhasen and H.S. Hathaway. 1965. Evidence for a new plasma thromboplastin factor I. Case report, coagulation studies and physico-chemical properties. Blood. 26: 521.
Kluft, C. 1978. Determination of prekallikrein in human plasma: Optimal conditions for activating prekallikrein. J. Lab. Clin. Med. 91: 83.
Kurkcuoglu, N. and A.E. Mc Elfresh. 1960. The Hageman factor: Determination of its concentration during the neonatal period and presentation of a case of Hageman factor deficiency. J. Pediatr. 57: 61.
Margolis, J. 1958. Activation of plasma by contact with glass: Evidence for a common reaction which releases plasma kinin and initiates coagulation. J. Physiol. ( Lond. ) 144: 1.
Mason, J.W., U.R. Kleeberg, P. Dolan and R.W. Colman, 1970. Plasma kallikrein and Hageman factor in gram-negative bacteremia. Ann. Intern. Med. 73: 545.
Ratnoff, O.D. and J.E. Colopy. 1955. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J. Clin. Invest. 34: 602.
Saito, H., O.D. Ratnoff and J. Pensky. 1976a. Radioimmunoassay of human Hageman factor (factor XII). J. Lab. Clin. Med. 88: 506.
Saito, H., G.H. Goldsmith and R. Waldmann. 1976b. Fitzgerald factor (high molecular weight kininogen) clotting activity in human plasma in health and disease, and in various animal plasmas. Blood. 48: 941.
Saito, H. and O.D. Ratnoff. 1977. Molecular heterogeneity of human plasma prekallikrein deficiency (Fletcher trait). Clin. Res. 25: 347A.
Saito, H., M.C. Poon, W. Vicic, G.H. Goldsmith and J.E. Menitove. 1978a. Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease. J. Lab. Clin. Med. 92: 84.
Saito, H., J.G. Scott, H.Z. Movat and S.J. Scialla. 1978b. CRM+ Hageman trait. Blood. 52: (supplement 1): 194.
Wuepper, K.D. 1973. Prekallikrein deficiency in man. J. Exp. Med. 138: 1345.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer Science+Business Media New York
About this chapter
Cite this chapter
Saito, H. (1979). Determination of Hageman Factor (HG, Factor XII) and Plasma Prekallikrein (Fletcher Factor) by Radioimmunoassays. In: Fujii, S., Moriya, H., Suzuki, T. (eds) Kinins—II. Advances in Experimental Medicine and Biology, vol 120. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-0926-1_16
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0926-1_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-0928-5
Online ISBN: 978-1-4757-0926-1
eBook Packages: Springer Book Archive